AlphaTON Capital explores tokenization for cancer drug program Oct 8, 2025 07:17AM
AlphaTON Capital and Subsidiary Cyncado Therapeutics Pioneer Convergence of Digital Assets and Oncology Innovation: Exploring Tokenization Framework for Mesothelioma Program as it Advances Toward Q1 2 Oct 8, 2025 07:16AM